Weight loss can feel like an uphill battle for women, especially as hormones shift with age. Join us as we dive into the buzz around GLP-1 medications—their risks, rewards, and the truth about rapid weight loss. 

In this episode, hosts Meredith Cunningham and Brooklyn Elbert welcome Dr. Ramya Undamatla, endocrinologist at Covenant Health, to break down what GLP-1 medications like Ozempic and Wegovy were originally designed for—managing type 2 diabetes—and how they’ve evolved into a popular option for weight management. Dr. Undamatla shares insights on how these medications work, who they’re appropriate for, and what women should consider before starting them. 

Dr. Ramya Undamatla Bio: 

Ramya Undamatla, board certified in Endocrinology and currently at Covenant Health’s Grace Clinic. She attended Manipal University, one of the top ten medical schools in India. She then completed her Internal medicine residency at Rutgers University/New Jersey medical school. To pursue her lifelong passion in Endocrinology, she relocated to the neighboring state of Pennsylvania where she completed her Endocrinology fellowship at the University of Pittsburgh Medical center. Dr. Undamatla finds joy in her long-term physician-patient relationships.